Search research articles
Contact Us
Filters
Showing results (101-110 of 153) with videos related to
Page
of 16
Sort By:
Journal of Internal Medicine
|
April 20, 2005
Prognostic value of erythrocyte sedimentation rate in ST segment elevation myocardial infarction: interaction with hyperglycaemia
J R Timmer, J P Ottervanger, J C A Hoorntje, et al.
The American Journal of Cardiology
|
January 31, 2006
Usefulness of biomarkers for predicting long-term mortality in patients with diabetes mellitus and non-ST-elevation acute coronary syndromes (a GUSTO IV substudy)
Stefan K James, Bertil Lindahl, Jorik R Timmer, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
|
May 16, 2020
Value of SiPM PET in myocardial perfusion imaging using Rubidium-82
S S Koenders, J A van Dalen, P L Jager, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
|
December 31, 2021
Semi-quantitative assessment of ischemia with rubidium-82 PET myocardial perfusion imaging
N M Borren, T J Gerritse, J P Ottervanger, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
October 8, 2014
The predictive value of proteinuria in acute pancreatitis
M J Zuidema, H C van Santvoort, M G Besselink, et al.
American Heart Journal
|
July 2, 2005
Glucose-insulin-potassium and reperfusion in acute myocardial infarction: rationale and design of the Glucose-Insulin-Potassium Study-2 (GIPS-2)
Iwan C C van der Horst, Jorik R Timmer, Jan Paul Ottervanger, et al.
Gastrointestinal Endoscopy
|
August 3, 2014
Prediction of response to endoscopic therapy of Barrett's dysplasia by using genetic biomarkers
Margriet R Timmer, Shannon M Brankley, Emmanuel C Gorospe, et al.
International Journal of Cardiology
|
January 16, 2007
One year outcomes after glucose-insulin-potassium in ST elevation myocardial infarction. The Glucose-insulin-potassium study II
Saman Rasoul, Jan Paul Ottervanger, Jorik R Timmer, et al.
BMC Family Practice
|
November 3, 2019
Design of the ZWOT-CASE study: an observational study on the effectiveness of an integrated programme for cardiovascular risk management compared to usual care in general practice
Suzanne Marchal, Monika Hollander, Marieke Schoenmakers, et al.
Archives of Internal Medicine
|
July 11, 2007
Primary percutaneous coronary intervention compared with fibrinolysis for myocardial infarction in diabetes mellitus: results from the Primary Coronary Angioplasty vs Thrombolysis-2 trial
Jorik R Timmer, Jan Paul Ottervanger, Menko-Jan de Boer, et al.
Page
of 16
Search research articles
Search
Showing results (101-110 of 153) with videos related to
Sort By:
Page
of 16
Journal of Internal Medicine
|
April 20, 2005
Prognostic value of erythrocyte sedimentation rate in ST segment elevation myocardial infarction: interaction with hyperglycaemia
J R Timmer, J P Ottervanger, J C A Hoorntje, et al.
The American Journal of Cardiology
|
January 31, 2006
Usefulness of biomarkers for predicting long-term mortality in patients with diabetes mellitus and non-ST-elevation acute coronary syndromes (a GUSTO IV substudy)
Stefan K James, Bertil Lindahl, Jorik R Timmer, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
|
May 16, 2020
Value of SiPM PET in myocardial perfusion imaging using Rubidium-82
S S Koenders, J A van Dalen, P L Jager, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
|
December 31, 2021
Semi-quantitative assessment of ischemia with rubidium-82 PET myocardial perfusion imaging
N M Borren, T J Gerritse, J P Ottervanger, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
October 8, 2014
The predictive value of proteinuria in acute pancreatitis
M J Zuidema, H C van Santvoort, M G Besselink, et al.
American Heart Journal
|
July 2, 2005
Glucose-insulin-potassium and reperfusion in acute myocardial infarction: rationale and design of the Glucose-Insulin-Potassium Study-2 (GIPS-2)
Iwan C C van der Horst, Jorik R Timmer, Jan Paul Ottervanger, et al.
Gastrointestinal Endoscopy
|
August 3, 2014
Prediction of response to endoscopic therapy of Barrett's dysplasia by using genetic biomarkers
Margriet R Timmer, Shannon M Brankley, Emmanuel C Gorospe, et al.
International Journal of Cardiology
|
January 16, 2007
One year outcomes after glucose-insulin-potassium in ST elevation myocardial infarction. The Glucose-insulin-potassium study II
Saman Rasoul, Jan Paul Ottervanger, Jorik R Timmer, et al.
BMC Family Practice
|
November 3, 2019
Design of the ZWOT-CASE study: an observational study on the effectiveness of an integrated programme for cardiovascular risk management compared to usual care in general practice
Suzanne Marchal, Monika Hollander, Marieke Schoenmakers, et al.
Archives of Internal Medicine
|
July 11, 2007
Primary percutaneous coronary intervention compared with fibrinolysis for myocardial infarction in diabetes mellitus: results from the Primary Coronary Angioplasty vs Thrombolysis-2 trial
Jorik R Timmer, Jan Paul Ottervanger, Menko-Jan de Boer, et al.
Page
of 16